{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:35:06Z","timestamp":1781199306639,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,3,13]],"date-time":"2012-03-13T00:00:00Z","timestamp":1331596800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s10384-012-0127-6","type":"journal-article","created":{"date-parts":[[2012,3,12]],"date-time":"2012-03-12T05:07:45Z","timestamp":1331528865000},"page":"214-218","source":"Crossref","is-referenced-by-count":34,"title":["Dacryoendoscopic observation and incidence of canalicular obstruction\/stenosis associated with S-1, an oral anticancer drug"],"prefix":"10.1007","volume":"56","author":[{"given":"Tsugihisa","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamon","family":"Miyanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsushi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,13]]},"reference":[{"key":"127_CR1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1470-2045(08)70035-4","volume":"9","author":"W Koizumi","year":"2008","unstructured":"Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9:215\u201321.","journal-title":"Lancet Oncol"},{"key":"127_CR2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/annonc\/mdf036","volume":"13","author":"B Esmaeli","year":"2002","unstructured":"Esmaeli B, Hortobagyi G, Esteva F, Valero V, Ahmadi MA, Booser D, et al. Canalicular stenosis secondary to weekly docetaxel: a potentially preventable side effect. Ann Oncol. 2002;13:218\u201321.","journal-title":"Ann Oncol"},{"key":"127_CR3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jama.1973.03220340051021","volume":"225","author":"J Hamersley","year":"1973","unstructured":"Hamersley J, Luce JK, Florentz TR, Burkholder MM, Pepper JJ. Excessive lacrimation from fluorouracil treatment. JAMA. 1973;225:747\u20138.","journal-title":"JAMA"},{"key":"127_CR4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1445-5994.1979.tb04317.x","volume":"9","author":"N Christophidis","year":"1979","unstructured":"Christophidis N, Vajda FJ, Lucas I, Louis WJ. Ocular side effects with 5-fluorouracil. Aust N Z J Med. 1979;9:143\u20134.","journal-title":"Aust N Z J Med"},{"key":"127_CR5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1001\/archopht.1981.03930010286013","volume":"99","author":"LP Caravella Jr","year":"1981","unstructured":"Caravella LP Jr, Burns JA, Zangmeister M. Punctal-canalicular stenosis related to systemic fluorouracil therapy. Arch Ophthalmol. 1981;99:284\u20136.","journal-title":"Arch Ophthalmol"},{"key":"127_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01203288","volume":"90","author":"HM Brink","year":"1995","unstructured":"Brink HM, Beex L. Punctal and canalicular stenosis associated with systemic fluorouracil therapy. Report of five cases and review of the literature. Doc Ophthalmol. 1995;90:1\u20136.","journal-title":"Doc Ophthalmol"},{"key":"127_CR7","first-page":"14","volume":"33","author":"A Hassan","year":"1998","unstructured":"Hassan A, Hurwitz JJ, Burkes RL. Epiphora in patients receiving systemic 5-fluorouracil therapy. Can J Ophthalmol. 1998;33:14\u20139.","journal-title":"Can J Ophthalmol"},{"key":"127_CR8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ajo.2005.01.052","volume":"140","author":"B Esmaeli","year":"2005","unstructured":"Esmaeli B, Golio D, Lubecki L, Ajani J. Canalicular and nasolacrimal duct blockage: an ocular side effect associated with the antineoplastic drug S-1. Am J Ophthalmol. 2005;140:325\u20137.","journal-title":"Am J Ophthalmol"},{"key":"127_CR9","first-page":"919","volume":"110","author":"S Ito","year":"2006","unstructured":"Ito S, Tanaka A. Three cases of corneal disorders associated with an oral anticancer drug S-1. Nippon Ganka Gakkai Zasshi. 2006;110:919\u201323.","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"127_CR10","first-page":"2896","volume":"15","author":"T Chikama","year":"2009","unstructured":"Chikama T, Takahashi N, Wakuta M, Nishida T. Noninvasive direct detection of ocular mucositis by in vivo confocal microscopy in patients treated with S-1. Mol Vis. 2009;15:2896\u2013904.","journal-title":"Mol Vis"},{"key":"127_CR11","first-page":"306","volume":"26","author":"ME Ashenhurst","year":"1991","unstructured":"Ashenhurst ME, Hurwitz JJ. Lacrimal canaliculoscopy: development of the instrument. Can J Ophthalmol. 1991;26:306\u20138.","journal-title":"Can J Ophthalmol"},{"key":"127_CR12","first-page":"57","volume":"10","author":"SW Cohen","year":"1979","unstructured":"Cohen SW, Prescott R, Sherman M, Banko W, Castillejos ME. Dacryoscopy. Ophthalmic Surg. 1979;10:57\u201363.","journal-title":"Ophthalmic Surg"},{"key":"127_CR13","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1001\/archopht.1992.01080240088037","volume":"110","author":"W Fein","year":"1992","unstructured":"Fein W, Daykhovsky L, Papaioannou T, Beeder C, Grundfest WS. Endoscopy of the lacrimal outflow system. Arch Ophthalmol. 1992;110:1748\u201350.","journal-title":"Arch Ophthalmol"},{"key":"127_CR14","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ajo.2005.07.038","volume":"140","author":"T Sasaki","year":"2005","unstructured":"Sasaki T, Nagata Y, Sugiyama K. Nasolacrimal duct obstruction classified by dacryoendoscopy and treated with inferior meatal dacryorhinotomy. Part I. Positional diagnosis of primary nasolacrimal duct obstruction with dacryoendoscope. Am J Ophthalmol. 2005;140:1065\u20139.","journal-title":"Am J Ophthalmol"},{"key":"127_CR15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10384-008-0624-9","volume":"53","author":"T Sasaki","year":"2009","unstructured":"Sasaki T, Sounou T, Sugiyama K. Dacryoendoscopic surgery and tube insertion in patients with common canalicular obstruction and ductal stenosis as a frequent complication. Jpn J Ophthalmol. 2009;53:145\u201350.","journal-title":"Jpn J Ophthalmol"},{"key":"127_CR16","first-page":"2000","volume":"5","author":"K Hirata","year":"1999","unstructured":"Hirata K, Horikoshi N, Aiba K, Okazaki M, Denno R, Sasaki K, et al. Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug. Clin Cancer Res. 1999;5:2000\u20135.","journal-title":"Clin Cancer Res"},{"key":"127_CR17","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00001813-199607000-00010","volume":"7","author":"T Shirasaka","year":"1996","unstructured":"Shirasaka T, Shimamato Y, Ohshimo H, Yamaguchi M, Kato T, Yonekura K, et al. Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs. 1996;7:548\u201357.","journal-title":"Anticancer Drugs"},{"key":"127_CR18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/cncr.22329","volume":"109","author":"HJ Lenz","year":"2007","unstructured":"Lenz HJ, Lee FC, Haller DG, Singh D, Benson AB 3rd, Strumberg D, et al. Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study. Cancer. 2007;109:33\u201340.","journal-title":"Cancer"},{"key":"127_CR19","first-page":"649","volume":"105","author":"JJ Woog","year":"2007","unstructured":"Woog JJ. The incidence of symptomatic acquired lacrimal outflow obstruction among residents of Olmsted County, Minnesota, 1976\u20132000 (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2007;105:649\u201366.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"127_CR20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1034\/j.1600-0420.2000.078001110.x","volume":"78","author":"S Prasad","year":"2000","unstructured":"Prasad S, Kamath GG, Phillips RP. Lacrimal canalicular stenosis associated with systemic 5-fluorouacil therapy. Acta Ophthalmol Scand. 2000;78:110\u20133.","journal-title":"Acta Ophthalmol Scand"},{"key":"127_CR21","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1002\/1097-0142(19851015)56:8<2148::AID-CNCR2820560845>3.0.CO;2-R","volume":"56","author":"SR Seiff","year":"1985","unstructured":"Seiff SR, Shorr N, Adams T. Surgical treatment of punctal-canalicular fibrosis from 5-fluorouracil therapy. Cancer. 1985;56:2148\u20139.","journal-title":"Cancer"},{"key":"127_CR22","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0002-9394(65)93004-7","volume":"59","author":"LT Jones","year":"1965","unstructured":"Jones LT. Conjunctivodacryocystorhinostomy. Am J Ophthalmol. 1965;59:773\u201383.","journal-title":"Am J Ophthalmol"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-012-0127-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-012-0127-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-012-0127-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:20:34Z","timestamp":1559146834000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-012-0127-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,13]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["127"],"URL":"https:\/\/doi.org\/10.1007\/s10384-012-0127-6","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,13]]}}}